Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study.

Warning

This publication doesn't include Faculty of Education. It includes Faculty of Medicine. Official publication website can be found on muni.cz.
Authors

KAPPOS Ludwig GOLD Ralf MILLER David H. MACMANUS David G. HAVRDOVÁ Eva LIMMROTH Volker POLMAN Chris H. SCHMIERER Klaus YOUSRY Tarek A. YANG Minhua ERAKSOY Mefkure MELUZÍNOVÁ Eva REKTOR Ivan DAWSON Katherine D. SANDROCK Alfred W. O'NEILL Gilmore N.

Year of publication 2008
Type Article in Periodical
Magazine / Source Lancet
MU Faculty or unit

Faculty of Medicine

Citation
Field Neurology, neurosurgery, neurosciences
Keywords Multiple sclerosis; multicentre; randomised; placebo
Description Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.